Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Current Oncology Reports|June 24, 2017
Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is HopeJonathan M Lehman, Mary E Gwin, Pierre P MassionCancer Journal (Sudbury, Mass.)|January 24, 2024
Telemedicine and Cancer Clinical Research: Opportunities for TransformationMitchell S von Itzstein, Mary E Gwin, Arjun Gupta, et al.Clinical Lung Cancer|June 6, 2025
Mortality in a Diverse, Real-World Lung Cancer Screening CohortMary E Gwin, Tanushree Prasad, Urooj Wahid, et al.Translational Lung Cancer Research|December 10, 2025
Association of PD-L1 expression with systemic immune parameters in non-small cell lung cancerMary E Gwin, Mitchell S von Itzstein, Jialiang Liu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net PopulationSheena Bhalla, Heidi A Hamann, Tanushree Prasad, et al.Research Square|December 8, 2025
Tobacco use and perceived risk of lung cancer in a safety-net populationMary E Gwin, Heidi A Hamann, Tanushree Prasad Ma, et al.JCO Clinical Cancer Informatics|March 7, 2025
Virtual Health Care Encounters for Lung Cancer Screening in a Safety-Net Population: Observations From the COVID-19 PandemicMary E Gwin, Urooj Wahid, Sheena Bhalla, et al.JTO Clinical and Research Reports|December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung CancerMitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.Biorxiv : the Preprint Server for Biology|June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to raceMitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.Journal for Immunotherapy of Cancer|September 10, 2025
Innate and adaptive immune features associated with immune-related adverse eventsShaheen Khan, Venkat S Malladi, Mitchell S von Itzstein, et al.Pageof 2